Asia-Pacific Regenerative Medicine Market - Growth, Trends, and Forecast (2020 - 2025)

The market is segmented By Type of Technology, Application (Bone Graft Substitutes, Osteoarticular Diseases, Dermatology, Cardiovascular, Central Nervous System and Other Applications) and Geography

Market Snapshot

Study Period:

2017-2025

Base Year:

2019

CAGR:

21.5 %

Major Players:

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Market Overview

Stem cell technology is a rapidly developing technology that plays a major role in regenerative medicine, as it also serves the disciplines of tissue engineering, developmental cell biology, cellular therapeutics, gene therapy, chemical biology, and nanotechnology. 

Stem cells offer the possibility of replacing the cells and tissues to treat various conditions and disabilities, including spinal cord injury, arthritis, and Parkinson’s disease, among others. Furthermore, stem cell and gene therapy offers potential cure for diseases, rather than long-term treatment, and shift the focus from treating to healing. The applications of stem cell technologies in the treatment of diseases have ultimately increased their adoption rate. Therefore, the rising adoption of stem cell technology, along with increasing research is expected to boost the market in the forecast period.

In addition, there are major technological advancements in biologics, biomaterials, stem cell technology, and tissue engineering, thus contributing to the market growth.

Scope of the report

As per the scope of the report, regenerative medicines are used to repair, replace, and regenerate the tissues and organs affected by injury, disease, or the natural aging process. These medicines restore the functionality of cells and tissues and are used in several degenerative disorders, such as dermatology, neurodegenerative diseases, cardiovascular, and orthopedic applications.

By Type of Technology
Stem Cell Therapy
Biomaterial
Tissue Engineering
Other Types of Technologies
By Application
Bone Graft Substitutes
Osteoarticular Diseases
Dermatology
Cardiovascular
Central Nervous System
Other Applications
Geography
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific

Report scope can be customized per your requirements. Click here.

Key Market Trends

Dermatology Segment is Expected to Show Better Growth in the Forecast Years

Based on Application, the market is segmented into Bone Graft Substitutes, Osteoarticular Diseases, Dermatology, Cardiovascular, Central Nervous System and Other Applications. The high growth in the dermatology segment is attributed to the presence of easy grafting techniques for dermatological wounds and diseases. 

Skin is one of the attractive model organs to test the novel concepts of regenerative medicine, with a specific emphasis on skin regeneration. There are also increasing of the chronic wounds that are rising every year. Therefore the tissue‐engineered skin substitutes represent an innovative option for the treatment of acute/chronic skin wounds. Bio-engineered skin replacements have now become substitutes for major physiological functions, by providing rapid and reliable cover for the defect, by reducing pain and discomfort for the patient. Hence, owing to these factors, the segment is expected to witness rapid growth over the forecast period.

To understand key trends, Download Sample Report

Competitive Landscape

The major players into the Asia-Pacific regenerative medicine market are Allergan plc, Baxter International Inc., Becton, Dickinson and Company, Cook Group Incorporated, Integra LifeSciences Corporation, Medtronic PLC, Merck KGaA, Smith & Nephew plc and Thermo Fisher Scientific. Therefore all these companies are making considerable investments in novel technologies, thus driving the market.

Table Of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Technological Advancements in Regenerative Medicine

      2. 4.2.2 Increasing Adoption of Stem Cell Technology

      3. 4.2.3 Rising Government Initiatives

    3. 4.3 Market Restraints

      1. 4.3.1 High Cost of Treatments

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Type of Technology

      1. 5.1.1 Stem Cell Therapy

      2. 5.1.2 Biomaterial

      3. 5.1.3 Tissue Engineering

      4. 5.1.4 Other Types of Technologies

    2. 5.2 By Application

      1. 5.2.1 Bone Graft Substitutes

      2. 5.2.2 Osteoarticular Diseases

      3. 5.2.3 Dermatology

      4. 5.2.4 Cardiovascular

      5. 5.2.5 Central Nervous System

      6. 5.2.6 Other Applications

    3. 5.3 Geography

      1. 5.3.1 Asia-Pacific

        1. 5.3.1.1 China

        2. 5.3.1.2 Japan

        3. 5.3.1.3 India

        4. 5.3.1.4 Australia

        5. 5.3.1.5 South Korea

        6. 5.3.1.6 Rest of Asia-Pacific

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Allergan plc

      2. 6.1.2 Baxter International Inc.

      3. 6.1.3 Becton, Dickinson and Company

      4. 6.1.4 Cook Group Incorporated

      5. 6.1.5 Integra LifeSciences Corporation

      6. 6.1.6 Medtronic PLC

      7. 6.1.7 Merck KGaA

      8. 6.1.8 Smith & Nephew plc (Osiris Therapeutics)

      9. 6.1.9 Thermo Fisher Scientific

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

** Subject to Availability

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

Related Reports